These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 13762497)

  • 21. Dihydroxyacetone: a safe camouflaging option in vitiligo.
    Rajatanavin N; Suwanachote S; Kulkollakarn S
    Int J Dermatol; 2008 Apr; 47(4):402-6. PubMed ID: 18377610
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Camouflage therapy workshop for pediatric dermatology patients: a review of 6 cases.
    Padilla-España L; del Boz J; Ramírez-López MB; Fernández-Sánchez ME
    Actas Dermosifiliogr; 2014 Jun; 105(5):510-4. PubMed ID: 24369988
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Dihydroxyacetone and its use in dermatology and cosmetics. (Review)].
    Rudowska I
    Z Haut Geschlechtskr; 1967 Nov; 42(21):649-53. PubMed ID: 5596906
    [No Abstract]   [Full Text] [Related]  

  • 24. The early repigmentation pattern of vitiligo is related to the source of melanocytes and by the choice of therapy: a retrospective cohort study.
    Yang K; Xiong X; Pallavi G; Ling Y; Ding F; Duan W; Sun W; Ding G; Gong Q; Zhu W; Lu Y
    Int J Dermatol; 2018 Mar; 57(3):324-331. PubMed ID: 29318595
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Depigmentation Therapies for Vitiligo.
    Grimes PE; Nashawati R
    Dermatol Clin; 2017 Apr; 35(2):219-227. PubMed ID: 28317530
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Factors influencing methoxsalen phototoxicity in vitiliginous skin.
    Arora SK; Willis I
    Arch Dermatol; 1976 Mar; 112(3):327-32. PubMed ID: 1259445
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tacalcitol and narrow-band phototherapy in patients with vitiligo.
    Leone G; Pacifico A; Iacovelli P; Paro Vidolin A; Picardo M
    Clin Exp Dermatol; 2006 Mar; 31(2):200-5. PubMed ID: 16487090
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Repigmentation of vitiligo-associated leukotrichia after autologous, non-cultured melanocyte-keratinocyte transplantation.
    Al Jasser MI; Ghwish B; Al Issa A; Mulekar SV
    Int J Dermatol; 2013 Nov; 52(11):1383-6. PubMed ID: 23834588
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The efficacy of pimecrolimus 1% cream combined with microdermabrasion in the treatment of nonsegmental childhood vitiligo: a randomized placebo-controlled study.
    Farajzadeh S; Daraei Z; Esfandiarpour I; Hosseini SH
    Pediatr Dermatol; 2009; 26(3):286-91. PubMed ID: 19706089
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Treatment of localized vitiligo with targeted broadband UVB phototherapy: a pilot study.
    Asawanonda P; Charoenlap M; Korkij W
    Photodermatol Photoimmunol Photomed; 2006 Jun; 22(3):133-6. PubMed ID: 16719866
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Repigmentation treatment of vitiligo with L-phenylalanine and UVA irradiation].
    Thiele B; Steigleder GK
    Z Hautkr; 1987 Apr; 62(7):519-23. PubMed ID: 3590916
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Diminished contact sensitivity response in vitiliginous skin.
    Uehara M; Miyauchi H; Tanaka S
    Arch Dermatol; 1984 Feb; 120(2):195-8. PubMed ID: 6696471
    [TBL] [Abstract][Full Text] [Related]  

  • 33. An objective assessment of melanin in vitiligo skin treated with Balneo PUVA therapy.
    Hegyi V; Petrovajová M; Novotný M
    Skin Res Technol; 2014 Feb; 20(1):108-15. PubMed ID: 23800185
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of a preceding fractional carbon dioxide laser on the outcome of combined local narrowband ultraviolet B and topical steroids in patients with vitiligo in difficult-to-treat areas.
    Vachiramon V; Chaiyabutr C; Rattanaumpawan P; Kanokrungsee S
    Lasers Surg Med; 2016 Feb; 48(2):197-202. PubMed ID: 26175036
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A randomized comparison of excimer laser versus narrow-band ultraviolet B phototherapy after punch grafting in stable vitiligo patients.
    Linthorst Homan MW; Spuls PI; Nieuweboer-Krobotova L; de Korte J; Sprangers MA; Bos JD; Wolkerstorfer A; van der Veen JP
    J Eur Acad Dermatol Venereol; 2012 Jun; 26(6):690-5. PubMed ID: 21711467
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Chinese cupping: a simple method to obtain epithelial grafts for the management of resistant localized vitiligo.
    Awad SS
    Dermatol Surg; 2008 Sep; 34(9):1186-92; discussion 1192-3. PubMed ID: 18537996
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Vitiligo: a comprehensive overview Part II: treatment options and approach to treatment.
    Felsten LM; Alikhan A; Petronic-Rosic V
    J Am Acad Dermatol; 2011 Sep; 65(3):493-514. PubMed ID: 21839316
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Treatment of vitiligo: advantages and disadvantages, indications for use and outcomes.
    Hossani-Madani A; Halder R
    G Ital Dermatol Venereol; 2011 Oct; 146(5):373-95. PubMed ID: 21956273
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Historical Evidence of Treating Vitiligo in Persia.
    Badr P; Handjani F; Mohagheghzadeh A
    Pharm Hist (Lond); 2016 Jun; 46(2):30-2. PubMed ID: 29999259
    [No Abstract]   [Full Text] [Related]  

  • 40. Autologous cultured melanocytes in vitiligo treatment.
    Czajkowski R; Placek W; Drewa T; Kowaliszyn B; Sir J; Weiss W
    Dermatol Surg; 2007 Sep; 33(9):1027-36; discussion 1035-6. PubMed ID: 17760593
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.